570 556 captures · dernière capture : 3 mai 2026
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
386 223 captures · dernière capture : 14 avr. 2026
243 880 captures · dernière capture : 28 avr. 2026
Qualifying notice for Carvykti Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e248805 Control number: 262122 [Employee name removed] [Employee title removed] Janssen Inc.…
Notice: Multiple Additions to the Prescription Drug List (PDL) [2023-03-08] March 8, 2023 Our file number: 23-101719-215 The purpose of this Notice of Amendment is to notify about the addition of cangrelor, ciltacabtagene autoleucel, deucravacitinib, pegcetacoplan and tirzepatide…
Notice to stakeholders – Clarification of requirements under the Food and Drug Regulations when conducting clinical trials with cannabis Important : this updated notice replaces the previous version that was published on May 31, 2021. March 9, 2023 Our file number: 23-101308-988…
Dear Health Care Professional Letter: Istodax (PDF Version - 158 K) Health Canada posts safety alerts, public health advisories, press releases and other notices from industry as a service to health professionals, consumers, and other interested parties. Although Health Canada…
Consultation: Proposed application of the definition of Canadian Reference Product (CRP) Current status: Closed This consultation ran from March 27, 2023 to May 12, 2023. Stakeholder feedback was received on a proposed application of the definition of Canadian Reference Product…
Qualifying notice for Columvi Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e244848 Control number: 265517 [Employee name removed] [Employee title removed] Hoffmann-La…
New Master File Application Form: Notice May 1, 2023 Our file number: 23-102532-292 On this page Background Important information Before you complete the new form Contact us Background Health Canada is revising the Master File Application Form and merging it with the Master File…
Qualifying notice for Thiotepa For Injection, BP Pharmaceutical Drugs Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier ID: HC6-024-e256254 Control number: 256254 Hikma Canada Limited [name of employee removed]…
Notice of Amendment: Correction to the Moxidectin Veterinary Listing on the Prescription Drug List (PDL) May 31, 2023 Our file number: 23‑104898-891 The purpose of this Notice of Amendment is to announce that Health Canada has amended the qualifier for the moxidectin listing on…
Veterinary drugs master file updates and fees consultation: Notice June 02, 2023 Our file number: 23-103954-307 On this page Background Important information Updates to process Fee consultation Contact us Background The Health Products and Food Branch (HPFB) will be updating…
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
